The debate on patents for seeds from new genetic engineering (NGT) reached a new political momentum in the spring of 2026: at the end of March 2026, the agricultural ministers' conference of the federal states voted in favour of a correction of the EU biopatent directive in order to limit the patentability of NGT plants. For breeders, farmers and IP practitioners, this raises the central question as to whether – and in what form – a patent ban o…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The debate on patents for seeds from new genetic engineering (NGT) reached a new political momentum in the spring of 2026: at the end of March 2026, the agricultural ministers' conference of the federal states voted in favour of a correction of the EU biopatent directive in order to limit the patentability of NGT plants. For breeders, farmers and IP practitioners, this raises the central question as to whether – and in what form – a patent ban o…